Trends in pediatric thyroid cancer incidence in the United States, 1998-2013
- PMID: 31012956
- PMCID: PMC6602875
- DOI: 10.1002/cncr.32125
Trends in pediatric thyroid cancer incidence in the United States, 1998-2013
Abstract
Background: Pediatric differentiated thyroid cancer (DTC) rates have increased over time in the United States and worldwide. Improvements in imaging for the diagnosis of DTC have been hypothesized as a potential driver of these increases. This study stratifies temporal trends in pediatric DTC by stage and tumor size to assess whether rates of large, late-stage cancers, which are likely to be clinically meaningful, are increasing over time.
Methods: Age-standardized incidence rates (ASRs) of DTC and annual percent changes (APCs) in primary DTC rates were estimated for 0- to 19-year-olds with data from 39 US cancer registries during 1998-2013.
Results: During 1998-2013, 7296 cases of DTC were diagnosed (6652 papillary cases and 644 follicular cases). APCs of pediatric DTCs significantly increased by 4.43%/y [95% CI, 3.74%/y-5.13%/y], primarily because of increases in papillary histologies. Increasing trends were observed for children aged 10 to 19 years for both sexes and for non-Hispanic whites, non-Hispanic blacks, and Hispanics. Rates increased significantly over the time period for all tumor stages (APClocalized , +4.06%/y [95% CI, 2.84%/y-5.29%/y]; APCregional , +5.68%/y [95% CI, 4.64%/y-6.73%/y]; APCdistant , +8.55%/y [95% CI, 5.03%/y-12.19%/y]) and across tumor sizes (APC<1 cm , +9.46%/y [95% CI, 6.13%/y-12.90%/y]; APC1-2 cm , +6.92%/y [95% CI, 4.31%/y-9.60%/y]; APC>2 cm , +4.69%/y [95% CI, 2.75%/y-6.67%/y]).
Conclusions: Significantly increasing rates of DTC over time among 10- to 19-year-olds in the United States are unlikely to be entirely explained by increases in medical surveillance during childhood because rates of large and late-stage DTC are increasing over time. Future studies should examine environmental and other factors that may be contributing to rising DTC rates.
Keywords: epidemiology; incidence; pediatrics; registries; thyroid cancer.
© 2019 American Cancer Society.
Conflict of interest statement
No conflict of interest disclosures
Figures





Comment in
-
Children and thyroid cancer: Interpreting troubling trends.Cancer. 2019 Jul 15;125(14):2359-2361. doi: 10.1002/cncr.32124. Epub 2019 Apr 23. Cancer. 2019. PMID: 31012950 No abstract available.
-
We cannot ignore the real component of the rise in thyroid cancer incidence.Cancer. 2019 Jul 15;125(14):2362-2363. doi: 10.1002/cncr.32123. Epub 2019 Apr 23. Cancer. 2019. PMID: 31012955 No abstract available.
-
Natural history of thyroid cancer suggests beginning of the overdiagnosis of juvenile thyroid cancer in the United States.Cancer. 2019 Nov 15;125(22):4107-4108. doi: 10.1002/cncr.32424. Epub 2019 Jul 29. Cancer. 2019. PMID: 31355907 No abstract available.
-
Harm of overdiagnosis or extremely early diagnosis behind trends in pediatric thyroid cancer.Cancer. 2019 Nov 15;125(22):4108-4109. doi: 10.1002/cncr.32426. Epub 2019 Jul 29. Cancer. 2019. PMID: 31355909 No abstract available.
References
-
- Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children: Diagnosis and management. Curr Opin Oncol 2008;20:59–65. - PubMed
-
- Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:1961–71. - PubMed
-
- Golpanian S, Perez EA, Tashiro J, Lew JI, Sola JE, Hogan AR. Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int 2016;32:201–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous